Microgynon

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2015
02419742015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
AIMS To assess the effect of maraviroc on the pharmacokinetics of midazolam, a sensitive probe CYP3A4 substrate; lamivudine… (More)
Is this relevant?
2001
2001
BACKGROUND AND OBJECTIVE Acne in women can often be successfully treated by the intake of oral contraceptives containing… (More)
Is this relevant?
1997
1997
Forty-three homozygous (SS) female sickle cell anemic patients with a history of at least one painful crisis per month and… (More)
Is this relevant?
1996
1996
The possibility of escape ovulation in women using a fluoroquinolone ofloxacin for antibacterial treatment at a dose of 200 mg… (More)
Is this relevant?
1995
1995
Combined hormonal oral contraceptives (OCs) may lead to a mild rise in blood pressure and body weight. In rare instances, large… (More)
Is this relevant?
1995
1995
The early days of oral contraceptives showed some evidence that these medications may have caused undesirable side effects on the… (More)
Is this relevant?
1992
1992
A randomised cross-over trial was performed to compare the pharmacodynamic actions of three low-dose oral contraceptives (OCs… (More)
Is this relevant?
1986
1986
The effect of deliberate omission of a phased formulation pill, Trinordiol (ethinyl estradiol 30 micrograms + levonorgestrel 50… (More)
Is this relevant?
1986
1986
The suppression of ovulation during the first treatment cycle with Microgynon 30 (150 micrograms levonorgestrel and 30 micrograms… (More)
Is this relevant?
1979
1979
The effects of deliberate omission of a Microgynon 30 (150 mcg of levonorgestrel and 30 mcg of ethinyl estradiol) tablet in the… (More)
Is this relevant?